Valuation: Avantor, Inc.

Market Cap 9.44B 8.1B 7.56B 6.94B 13.05B 902B 13.26B 89.24B 34.94B 453B 35.45B 34.68B 1,497B P/E 2026 *
41.8x
P/E 2027 * 29.9x
Enterprise Value 12.51B 10.73B 10.02B 9.2B 17.29B 1,196B 17.58B 118B 46.32B 600B 46.99B 45.97B 1,983B EV / Sales 2026 *
1.9x
EV / Sales 2027 * 1.76x
Free-Float
95.49%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 18/08/2025
Director of Finance/CFO 50 24/06/2026
Chief Operating Officer - 10/11/2025
Director TitleAgeSince
Director/Board Member 60 22/04/2020
Chairman 69 01/01/2026
Director/Board Member 62 01/10/2021
Date Insider Type Main position Quantity % Market Cap.
14/8/26 Tax

Head of Human Resources

-181 0.0000%
31/7/26 Tax

Chief Financial Officer

-1,385 0.0002%
24/7/26 Tax

Compliance Officer

-1,201 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+2.04%+0.22% - - 9.44B
+0.08%+2.91%-13.54%+10.24% 198B
-0.62%+3.36%+0.43%+14.72% 120B
-0.46%+1.75%+3.87%+74.30% 60.51B
-0.69%-4.97%+30.57%+60.51% 53.64B
+0.13%+3.43%-5.51%-31.71% 51.1B
+0.82%-0.98%+10.91%-13.47% 33.92B
-1.42%-6.01% - - 29.75B
+1.15%+2.80%+44.43%-9.38% 24.83B
+4.23%-1.68%-6.80%+25.10% 23.01B
Average +0.52%-0.23%+8.05%+16.29% 60.47B
Weighted average by Cap. +0.02%+1.40%+0.50%+17.35%

Financials

2026 *2027 *
Net sales 6.59B 5.66B 5.28B 4.85B 9.11B 630B 9.26B 62.32B 24.4B 316B 24.76B 24.22B 1,045B 6.75B 5.79B 5.41B 4.96B 9.33B 645B 9.48B 63.8B 24.98B 324B 25.34B 24.79B 1,070B
Net income 225M 193M 180M 165M 311M 21.52B 316M 2.13B 833M 10.79B 845M 827M 35.68B 311M 267M 249M 228M 429M 29.7B 437M 2.94B 1.15B 14.9B 1.17B 1.14B 49.26B
Net Debt 3.07B 2.64B 2.46B 2.26B 4.25B 294B 4.32B 29.04B 11.37B 147B 11.54B 11.29B 487B 2.44B 2.09B 1.96B 1.79B 3.37B 233B 3.43B 23.07B 9.04B 117B 9.17B 8.97B 387B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Date Price Change Volume
21/08/26 USD 14.24 +1.97% 1,600,060
19/08/26 USD 13.96 +4.73% 6,421,212
18/08/26 USD 13.33 -1.26% 6,310,268
17/08/26 USD 13.50 -1.17% 4,537,083
14/08/26 USD 13.66 -1.37% 3,964,759
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
13.96USD
Average target price
14.56USD
Spread / Average Target
+4.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AVTR Stock